Search NLS News

Swedish pharmaceutical exports continue to develop positively according to new figures from Statistics Sweden (SCB). Sweden’s total exports increased by 4 percent in value and two percent in volume during the second quarter of 2024 compared to the same time period in 2023. Pharmaceutical exports increased during the period by 9 percent in value and […]

Rokote Laboratories Finland has selected 3PBIOVIAN as their CDMO partner for GMP manufacturing of adenovirus type 5 (Ad5) vector-based candidate expressing a modified spike protein of severe acute respiratory coronavirus 2. 3PBIOVIAN will provide Rokote Laboratories with Drug Substance and Drug Product to bring the intranasal FINCoVac 2.1 vaccine into Phase I clinical studies. The […]

Swedish pharmaceutical exports continue to develop positively according to new figures from Statistics Sweden (SCB). Sweden’s total exports increased by 4 percent in value and two percent in volume during the second quarter of 2024 compared to the same time period in 2023. Pharmaceutical exports increased during the period by 9 percent in value and […]

An agreement has been signed between Oslo City Council and Oslo Science Hub to sell the lots necessary for the planned building that will transform the Oslo Montebello area into an international power centre for cancer research. “Our vision is to create a vital and inclusive environment where researchers, entrepreneurs and companies at the Radium […]

AstraZeneca is making an additional investment of USD 135 million in its facility for biologics in Södertälje. “We are happy about this investment in Södertälje, which demonstrates AstraZeneca’s commitment to innovation and manufacturing of biological medicines in Sweden,” says Per Alfredsson, CEO of AstraZeneca AB and Senior Vice President for Global Biologics Operations. The investment […]

In a new publication in “Vaccines” from Department of Immunology and Microbiology, Centre for translational Medicine & Parasitology at Copenhagen University, Attana’s technology has been applied to determine the interaction kinetics between antibodies from vaccinated mice and the pathogen antigen used for the vaccines. This provides valuable information for creating a vaccine with optimal neutralizing […]

Getinge has announced an agreement to acquire 100% of Paragonix Technologies for an aggregated purchase price, including upfront and earn out payments, estimated to approximately USD 477 million. The acquisition aligns with Getinge’s broader strategy to expand its portfolio into high growth markets that complement and enhance its acute heart and lung support offering already […]

NADMED has closed a series A round to fund its entry into the U.S. and other international markets with its nicotinamide adenine dinucleotide (NAD) measurement technology that may help clinicians establish more precise and personalized treatments for various diseases. The round was led by Finnish science-based startup investor Nordic Science Investments (NSI). Additional funding was secured […]

The Swedish biotech company has entered into a research collaboration agreement with Eli Lilly and Company to apply its AbiProt technology to generate antibodies against a well-validated target protein. This partnership aims to accelerate research and development of innovative treatments and, if successful, will generate milestone payments and royalty income, states the company. Under the […]

AlgoDx has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its sepsis detection software using an algorithm, NAVOY CDS. This milestone marks a major step forward in AlgoDx’s expansion into the U.S. market, states the company. NAVOY CDS NAVOY CDS is a software as a medical device (SaMD) designed to support […]